57 related articles for article (PubMed ID: 26117056)
1. [Expression and Clinical Significance of Lymphoid Enhancer-Binding Factor 1 in Acute Leukemias].
Huo WY; Gao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):888-91. PubMed ID: 26117056
[TBL] [Abstract][Full Text] [Related]
2. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
3. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
[TBL] [Abstract][Full Text] [Related]
5. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
Gehrke I; Gandhirajan RK; Kreuzer KA
Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
[TBL] [Abstract][Full Text] [Related]
6. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
7. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
Lee Y; Piao HL; Kim J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.
Albano F; Zagaria A; Anelli L; Orsini P; Minervini CF; Impera L; Casieri P; Coccaro N; Tota G; Brunetti C; Minervini A; Pastore D; Carluccio P; Mestice A; Cellamare A; Specchia G
Oncotarget; 2014 Feb; 5(3):649-58. PubMed ID: 24378360
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid enhancer-binding factor 1 expression precedes dentin sialophosphoprotein expression during rat odontoblast differentiation and regeneration.
Nakatomi M; Ida-Yonemochi H; Ohshima H
J Endod; 2013 May; 39(5):612-8. PubMed ID: 23611378
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
12. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
[TBL] [Abstract][Full Text] [Related]
14. Role of Lef1 in sustaining self-renewal in mouse embryonic stem cells.
Huang C; Qin D
J Genet Genomics; 2010 Jul; 37(7):441-9. PubMed ID: 20659708
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.
Santiago L; Daniels G; Wang D; Deng FM; Lee P
Am J Cancer Res; 2017; 7(6):1389-1406. PubMed ID: 28670499
[TBL] [Abstract][Full Text] [Related]
16. Lef1 regulates COX-2 transcription in chondrocytes.
Yun K; Im SH
Biochem Biophys Res Commun; 2007 Dec; 364(2):270-5. PubMed ID: 17945188
[TBL] [Abstract][Full Text] [Related]
17. FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) mice.
Kratochwil K; Galceran J; Tontsch S; Roth W; Grosschedl R
Genes Dev; 2002 Dec; 16(24):3173-85. PubMed ID: 12502739
[TBL] [Abstract][Full Text] [Related]
18. [Mutation and expression of LEF1 in adult acute lymphocytic leukemia and their clinical significance].
Liu J; Guo X; Ge Z; Zhang R; Xu JY; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1212-6. PubMed ID: 25338559
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid enhancer binding factor 1 regulates transcription through gene looping.
Yun K; So JS; Jash A; Im SH
J Immunol; 2009 Oct; 183(8):5129-37. PubMed ID: 19783677
[TBL] [Abstract][Full Text] [Related]
20. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
Wilusz M; Majka M
Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
